The reiteration of the 'Sector Perform' rating and maintenance of the $71 price target by RBC Capital suggests a neutral outlook on Axonics. This indicates that the analyst believes Axonics is fairly valued at its current price, suggesting no significant short-term price movement is expected based on this analysis alone.